Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3163-3173
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3163
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3163
Figure 1 Markov models for hepatitis C virus (A) and alcoholic liver disease (B).
- Citation: Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World J Gastroenterol 2017; 23(17): 3163-3173
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3163.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3163